drugset / Trial / NCT01754844

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

NCT01754844 ↗

Phase 1 Completed 57 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindBasic science

Summary

This is a First in Human study to assess the safety and tolerability of AZD7624, following inhaled administration of single ascending doses in healthy male volunteers and female volunteers of non-child bearing potential. Pharmacokinetics (what the body does to the drug) and pharmacodynamic (what the drug does to the body) parameters will be also assessed as secondary objectives.

Timeline

Start
2013-01
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7624 Small molecule — Inhaled